Such an important topic!Sex-related eligibility criteria leading to exclusion of women from clinical trials. @hvanspall proposes pragmatic eligibility criteria facilitating enrolment of women &URM in RCTs
#CVCT2021 @CVCTForum @SantosGallegoMD @DrRaniKhatib @drdargaray Brilliant slide by @hvanspall on strategies to increase diversity in clinical trials
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @Drroxmehran @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela

Dominick Angiolillo on the dilemma of perioperative antiplatelet therapy
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela @cristina_gavina Some great insights on limitations of perioperative antiplatelet Rx & limitations of guidelines - the issue perioperative antiplatelet and HBR are not the same! #CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @DrRajivsankar @FaiezZANNAD @DLBHATTMD

The regulatory viewpoint of endpoints in antithrombotic therapy trials by Ellis Unger #CVCT #iCVCT @docbhardwaj @DrRajivsankar @DrRaniKhatib @SantosGallegoMD @CMichaelGibson @hvanspall @CVCTForum @rachkataria @lucreciamburgos @AHajduczok @Drroxmehran @djc795 @A_FelixOliveira The regulatory viewpoint of endpoints in antithrombotic therapy trials by Ellis Unger #CVCT2021 @docbhardwaj @DrRajivsankar @DrRaniKhatib @SantosGallegoMD @CMichaelGibson @hvanspall @CVCTForum @rachkataria @lucreciamburgos @AHajduczok @DjawidHashemi @BoldiKovacsMD @ZainabDakhil2

#ICPeeps next up: the first session of #iCVCT #CVCT2021 on hemodynamic support trials with ⭐ panel
@alaide_chief @NavinKapur4 @thiele_holger @georgedangas et al.

@CVCTForum @Drroxmehran @CMichaelGibson @mirvatalasnag @ShrillaB @Babar_Basir @adityadoc1 @DrRaniKhatib @ShrillaB Despite ESC recommendations IABP remains most widely used MCS in Germany: European perspectives and trends in MCS by @alaide_chief
#CVCT #iCVCT @NavinKapur4 @thiele_holger @georgedangas @CVCTForum @Drroxmehran @ShrillaB @Babar_Basir @adityadoc1 @DrRaniKhatib @docbhardwaj

fantastic takeaway slides on subgroup analyses & secondary results publications by @FaiezZANNAD
#CVCT2021 @hvanspall @DjawidHashemi @rachkataria @SantosGallegoMD @AlexNowbar @DrRajivsankar @cristina_gavina @A_FelixOliveira @BoldiKovacsMD @docbhardwaj @drdargaray Dr Joseph Hill @CircAHA on the nuances and challenges with publishing artificial intelligence analyses of trial databases:
#CVCT2021 @hvanspall @rachkataria @SantosGallegoMD @AlexNowbar @DrRajivsankar @cristina_gavina @A_FelixOliveira @BoldiKovacsMD @docbhardwaj @drdargaray

#ESCCongress When coronary angiography is not enough: @RaberLorenz turns on the light with #OCT –
🔦ACS-⬆️resolution of OCT -gold standard to ID thrombus, ID unclear culprit, ACS aetiology, rule-in & rule-out
🔦#MINOCA
🔦Stent thombosis
🔦Optimize PCI
@mirvatalasnag @Hragy Phenomenal talk oy @MaeharaAkiko : SCenarios where #IVUSis gold-standard

#ESCCongress @sbrugaletta @ziadalinyc @SanjogKalra @NishithChandra @APSIC6 @w_jyg @DrAnkushG @care4urheart2 @ShrillaB @chadialraies @cardioPCImom @ANazmiCalik @GeminaDB @KVM83 @ShaziaTHussain1

#EuroPCR Physiology-guided imaging case of stagedPCI to RCA in a patient with MVD from Imperial
- now in the Main Arena
@rallamee @SukhNijjer

@ANazmiCalik @ShaziaTHussain1 @ShrillaB @TharushaGunawa4 @NicolaRyanI1 @AsherElad @Ortega_Paz @ezmanshariff @DrAllenJ @mirvatalasnag #EuroPCR Setting up the Omniwire for physiologic assessment

@PCRonline

#ACC21 late-breakers🧵
1/Antiplatelets: Let's start with #aspirin
❌ADAPTABLE :Aspirin 325 mg vs 81 mg in ASCVD pts
No difference in death/ MI/ stroke/major bleeding
💎pragmatic trial: EHR-identified pts
💎significant dose switching in 325 mg group
nejm.org/doi/full/10.10… ✅Host Exam: Aspirin vs Clopidogrel in chronic Maintenance monotherapy after #PCI w/ DES
#Clopidogrel monotherapy reduced composite of death, non-fatal MI, stroke, ACS re-admission, BARC >=3 bleeding, compared to #aspirin monotherapy.
❓East Asian paradox
thelancet.com/journals/lance…